Resources

Myricx Bio announces that it has been awarded the Cancer Research Horizons Start-Up Achievement Recognition Award for 2025, which it received at a ceremony in London last night.

The government has today launched a bold new Life Sciences Sector Plan as part of the government’s flagship Industrial Strategy.

Responding to the Life Sciences Sector Plan, BIA Chair Dr Daniel Mahony said the following.

Cellular Origins, the Cell and Gene Therapy Catapult and Resolution Therapeutics today announce the formation of a consortium which has been awarded a cross-industry Smart Grant of £1 million from Innovate UK, the UK’s national innovation agency.

Coulter Partners successfully completed a search assignment for QBiotics Group Limited (QBiotics) and announces the placement of Sergio Duchini as Non-executive Director.

PIR International spoke with the Chief Executive Officer of Muna Therapeutics, Rita Balice-Gordon, as part of their BioLeader interview series.

Cancer Research Horizons, the innovation arm of Cancer Research UK, has announced the winners of its third Innovation and Entrepreneurship Awards.

MSD's record-breaking $10 billion acquisition of Verona Pharma illustrates the potential of our sector, but also is a reminder of the need to strengthen UK capital markets.

The BioIndustry Association (BIA) today announces that Canary Wharf Group (CWG) and Kadans Science Partner (Kadans) have joined as annual supporters. This is a move that speaks to the strength of BIA and the vitality of the UK life sciences ecosystem.

In this blog, James Buckley-Walker, Partner, 3PM, shares his vision of a smarter, more human-focused approach to lab design and operation.

Today, the British Business Bank has announced a new £400 million Investor Pathways Capital initiative, which will support diverse and emerging fund managers across the economy and make it easier for new entrants, particularly those from underrepresented groups, to break into venture capital.

In this article, Kate Barclay, Skills Strategy Consultant at BIA, outlines new changes to UK immigration law and how they will impact the life sciences sector. Prepared in collaboration with legal experts at Eversheds-Sutherland LLP.

In this blog, Albert Maguire-King, Media and Communications Executive at the BIA, shares the vision of hope witnessed at BIA's recent TechBio X event in Cambridge.

Coulter Partners successfully completed a search assignment for Biomia and is pleased to announce the placement of Frederick Westhorpe, PhD as Chief Scientific Officer (CSO).

NHS 10 Year Health Plan for England, a strategy for European Life Sciences and hope to see you at the “sunny” BIA Summer Party on Wednesday.

In this blog, Sarah Potter, Partner - Patent Attorney and Robert Cogger-Ward, Associate at Potter Clarkson, share what you need to know about DSI and the Cali Fund.

Coulter Partners successfully completed search assignments for Augustine Therapeutics NV.

Hosted at West Road Concert Hall in Cambridge, the Symposium brings together leading minds from academia and industry to showcase cutting-edge research and its translation into novel therapeutics.